Import and spread of Panton-Valentine leukocidin-positive staphylococcus aureus through nasal carriage and skin infections in travelers returning from the tropics and subtropics

Clinical Infectious Diseases

Volumn 54, Issue 4, 2012, Pages 483-492

  Zanger, Philipp ^a   Nurjadi, Dennis ^a   Schleucher, Regina ^a,d   Scherbaum, Helmut ^c   Wolz, Christiane ^b   Kremsner, Peter G ^a   Schulte, Berit ^b  

^a Institut fur Tropenmedizin   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c Paul Lechler Krankenhaus   (Germany)

^d Tropmed Ruhr   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CEFOXITIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; METICILLIN; PANTON VALENTINE LEUKOCIDIN;

ADULT; AFRICA; ANTIBIOTIC SENSITIVITY; ARTICLE; ASIA; AUSTRALIA; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENOTYPE; HUMAN; MALE; PRIORITY JOURNAL; SOFT TISSUE INFECTION; SOUTH AND CENTRAL AMERICA; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS AUREUS; TRAVEL;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CARRIER STATE; CASE-CONTROL STUDIES; EXOTOXINS; FEMALE; GEOGRAPHY; HUMANS; LEUKOCIDINS; MALE; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; SKIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; TRAVEL; TROPICAL CLIMATE; VIRULENCE FACTORS; WORLD HEALTH;

EID: 84856753656     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir822     Document Type: Article

References (57)

1. Zanger P. Staphylococcus aureus positive skin infections and international travel. Wien Klin Wochenschr 2010; 122(Suppl 1):31-3.
2. Lederman ER, Weld LH, Elyazar IR, et al. Dermatologic conditions of the ill returned traveler: an analysis from the GeoSentinel Surveillance Network. Int J Infect Dis 2008; 12:593-602.
3. Hochedez P, Canestri A, Lecso M, Valin N, Bricaire F, Caumes E. Skin and soft tissue infections in returning travelers. Am J Trop Med Hyg 2009; 80:431-4.
4. Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab Invest 2007; 87:3-9. (Pubitemid 44973648)
5. Durupt F, Mayor L, Bes M, et al. Prevalence of Staphylococcus aureus toxins and nasal carriage in furuncles and impetigo. Br J Dermatol 2007; 157:1161-7. (Pubitemid 350115678)
6. Lina G, Piemont Y, Godail-Gamot F, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999; 29:1128-32. (Pubitemid 30265628)
7. Schleucher RD, Gaessler M, Knobloch J. Panton-Valentine leukocidinproducing methicillin-sensitive Staphylococcus aureus as a cause for recurrent, contagious skin infections in young, healthy travelers returned from a tropical country: a new worldwide public health problem? J Travel Med 2008; 15:137-9. (Pubitemid 351393040)
8. Helgason KO, Jones ME, Edwards G. Panton-valentine leukocidinpositive Staphylococcus aureus and foreign travel. J Clin Microbiol 2008; 46:832-3. (Pubitemid 351231353)
9. Lesens O, Haus-Cheymol R, Dubrous P, et al. Methicillin-susceptible, doxycycline-resistant Staphylococcus aureus, Cote d'Ivoire. Emerg Infect Dis 2007; 13:488-90.
10. Tappe D, Schulze MH, Oesterlein A, et al. Panton-Valentine leukocidinpositive Staphylococcus aureus infections in returning travelers. Am J Trop Med Hyg 2010; 83:748-50.
11. Maier J, Melzl H, Reischl U, et al. Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus in Germany associated with travel or foreign family origin. Eur J Clin Microbiol Infect Dis 2005; 24:637-9. (Pubitemid 41456148)
12. Stenhem M, Ortqvist A, Ringberg H, et al. Imported methicillinresistant Staphylococcus aureus, Sweden. Emerg Infect Dis 2010; 16:189-96.
13. Rasigade JP, Laurent F, Lina G, et al. Global distribution and evolution of Panton-Valentine leukocidin-positive methicillin-susceptible Staphylococcus aureus, 1981-2007. J Infect Dis 2010; 201:1589-97.
14. Robinson DA, Kearns AM, Holmes A, et al. Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillinresistant clone. Lancet 2005; 365:1256-8. (Pubitemid 40469658)
15. Orscheln RC, Hunstad DA, Fritz SA, et al. contribution of genetically restricted, methicillin-susceptible strains to the ongoing epidemic of community-acquired Staphylococcus aureus infections. Clin Infect Dis 2009; 49:536-42.
16. Monecke S, Slickers P, Ellington MJ, Kearns AM, Ehricht R. High diversity of Panton-Valentine leukocidin-positive, methicillin-susceptible isolates of Staphylococcus aureus and implications for the evolution of community-associated methicillin-resistant S. aureus. Clin Microbiol Infect 2007; 13:1157-64. (Pubitemid 350056120)
17. Nübel U, Roumagnac P, Feldkamp M, et al. Frequent emergence and limited geographic dispersal of methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci USA 2008; 105:14130-5.
18. Harmsen D, Claus H, Witte W, et al. Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol 2003; 41:5442-8. (Pubitemid 37543228)
19. Aanensen DM, Spratt BG. The multilocus sequence typing network: mlst.net. Nucleic Acids Res 2005; 33:W728-33. (Pubitemid 44530019)
20. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin- susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000; 38:1008-15. (Pubitemid 30140551)
21. Oliveira DC, de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46:2155-61. (Pubitemid 34665910)
22. Schlichting C, Branger C, Fournier JM, et al. Typing of Staphylococcus aureus by pulsed-field gel electrophoresis, zymotyping, capsular typing, and phage typing: resolution of clonal relationships. J Clin Microbiol 1993; 31:227-32. (Pubitemid 23028615)
23. Tristan A, Bes M, Meugnier H, et al. Global distribution of Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 2007; 13:594-600. (Pubitemid 46525107)
24. Ridom SpaServer. Available at: http://spa.ridom.de. Accessed 13 February 2011.
25. Breurec S, Fall C, Pouillot R, et al. Epidemiology of methicillinsusceptible Staphylococcus aureus lineages in five major African towns: high prevalence of Panton-Valentine leukocidin genes. Clin Microbiol Infect 2011; 17:633-9.
26. Goering RV, Shawar RM, Scangarella NE, et al. Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates from global clinical trials. J Clin Microbiol 2008; 46:2842-7.
27. Aires-de-Sousa M, Conceicao T, de Lencastre H. Unusually high prevalence of nosocomial Panton-Valentine leukocidin-positive Staphylococcus aureus isolates in Cape Verde Islands. J Clin Microbiol 2006; 44: 3790-3. (Pubitemid 46768808)
28. Breurec S, Zriouil SB, Fall C, et al. Epidemiology of methicillinresistant Staphylococcus aureus lineages in five major African towns: emergence and spread of atypical clones. Clin Microbiol Infect 2010; 17:160-5.
29. Ghebremedhin B, Olugbosi MO, Raji AM, et al. Emergence of a community-associated methicillin-resistant Staphylococcus aureus strain with a unique resistance profile in Southwest Nigeria. J Clin Microbiol 2009; 47:2975-80.
30. Ruimy R, Maiga A, Armand-Lefevre L, et al. The carriage population of Staphylococcus aureus from Mali is composed of a combination of pandemic clones and the divergent Panton-Valentine leukocidinpositive genotype ST152. J Bacteriol 2008; 190:3962-8. (Pubitemid 351732876)
31. Bekkhoucha SN, Cady A, Gautier P, Itim F, Donnio PY. A portrait of Staphylococcus aureus from the other side of the Mediterranean Sea: molecular characteristics of isolates from western Algeria. Eur J Clin Microbiol Infect Dis 2009; 28:553-5.
32. Enany S, Yaoita E, Yoshida Y, Enany M, Yamamoto T. Molecular characterization of Panton-Valentine leukocidin-positive communityacquired methicillin-resistant Staphylococcus aureus isolates in Egypt. Microbiol Res 2010; 165:152-62.
33. D'Souza N, Rodrigues C, Mehta A. Molecular characterization of methicillin-resistant Staphylococcus aureus with emergence of epidemic clones of sequence type (ST) 22 and ST 772 in Mumbai, India. J Clin Microbiol 2010; 48:1806-11.
34. Ellington MJ, Ganner M, Warner M, Cookson BD, Kearns AM. Polyclonal multiply antibiotic-resistant methicillin-resistant Staphylococcus aureus with Panton-Valentine leucocidin in England. J Antimicrob Chemother 2010; 65:46-50.
35. Neela V, Ehsanollah GR, Zamberi S, Van Belkum A, Mariana NS. Prevalence of Panton-Valentine leukocidin genes among carriage and invasive Staphylococcus aureus isolates in Malaysia. Int J Infect Dis 2009; 13:e131-2.
36. Afroz S, Kobayashi N, Nagashima S, et al. Genetic characterization of Staphylococcus aureus isolates carrying Panton-Valentine leukocidin genes in Bangladesh. Jpn J Infect Dis 2008; 61:393-6.
37. Yao D, Yu FY, Qin ZQ, et al. Molecular characterization of Staphylococcus aureus isolates causing skin and soft tissue infections (SSTIs). BMC Infect Dis 2010; 10:133.
38. Yu F, Chen Z, Liu C, et al. Prevalence of Staphylococcus aureus carrying Panton-Valentine leukocidin genes among isolates from hospitalised patients in China. Clin Microbiol Infect 2008; 14:381-4. (Pubitemid 351356531)
39. Liu Y, Wang H, Du N, et al. Molecular evidence for spread of two major methicillin-resistant Staphylococcus aureus clones with a unique geographic distribution in Chinese hospitals. Antimicrob Agents Chemother 2009; 53:512-8.
40. Zhang W, Shen X, Zhang H, et al. Molecular epidemiological analysis of methicillin-resistant Staphylococcus aureus isolates from Chinese pediatric patients. Eur J Clin Microbiol Infect Dis 2009; 28:861-4.
41. Multilocus sequence typing. Available at: http://saureus.mlst.net/. Accessed 13 February 2011.
42. Nimmo GR, Coombs GW, Pearson JC, et al. Methicillin-resistant Staphylococcus aureus in the Australian community: an evolving epidemic. Med J Aust 2006; 184:384-8.
43. Tong SY, Lilliebridge RA, Bishop EJ, et al. Clinical correlates of Panton-Valentine leukocidin (PVL), PVL isoforms, and clonal complex in the Staphylococcus aureus population of Northern Australia. J Infect Dis 2010; 202:760-9.
44. Muttaiyah S, Coombs G, Pandey S, et al. Incidence, risk factors, and outcomes of Panton-Valentine leukocidin-positive methicillinsusceptible Staphylococcus aureus infections in Auckland, New Zealand. J Clin Microbiol 2010; 48:3470-4.
45. Reyes J, Rincon S, Diaz L, et al. Dissemination of methicillin-resistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America. Clin Infect Dis 2009; 49:1861-7.
46. Denis O, Deplano A, De Beenhouwer H, et al. Polyclonal emergence and importation of community-acquired methicillin-resistant Staphylococcus aureus strains harbouring Panton-Valentine leucocidin genes in Belgium. J Antimicrob Chemother 2005; 56:1103-6. (Pubitemid 43009827)
47. Vivoni AM, Diep BA, de Gouveia Magalhaes AC, et al. Clonal composition of Staphylococcus aureus isolates at a Brazilian university hospital: identification of international circulating lineages. J Clin Microbiol 2006; 44:1686-91. (Pubitemid 43726256)
48. Tokajian ST, Khalil PA, Jabbour D, et al. Molecular characterization of Staphylococcus aureus in Lebanon. Epidemiol Infect 2010; 138: 707-12.
49. Voyich JM, Otto M, Mathema B, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 2006; 194:1761-70. (Pubitemid 44902009)
50. Diep BA, Otto M. The role of virulence determinants in communityassociated MRSA pathogenesis. Trends Microbiol 2008; 16:361-9.
51. Otto M. Basis of virulence in community-associated methicillinresistant Staphylococcus aureus. Annu Rev Microbiol 2010; 64:143-62.
52. Raz R,Miron D, Colodner R, Staler Z, Samara Z, Keness Y. A 1-year trial of nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization and skin infection. Arch Intern Med 1996; 156:1109-12. (Pubitemid 26158068)
53. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillinresistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011; 52:285-92.
54. Cooke FJ, Brown NM. Community-associated methicillin-resistant Staphylococcus aureus infections. Br Med Bull 2010; 94:215-27.
55. Miller LG, Perdreau-Remington F, Bayer AS, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillinsusceptible S. aureus infection: a prospective investigation. Clin Infect Dis 2007; 44:471-82. (Pubitemid 46233247)
56. Schaumburg F, Kock R, Friedrich AW, et al. Population structure of Staphylococcus aureus from remote African Babongo Pygmies. PLoS Negl Trop Dis 2011; 5:e1150.
57. Steffen R. Epidemiology of traveler's diarrhea. Clin Infect Dis 2005; 41(Suppl 8):S536-40. (Pubitemid 41691583)